Trial intelligence / Profile preview

Miralax vs Senna for Pediatric Colonoscopy Prep

NCT01140295Phase 4Terminated

Sponsor
Children's Hospital of Philadelphia
Start
Sep 2010
Primary completion
May 2011
Modality
Injectable Hydrogels, Implantable Hydrogels, Biodegradable Polymers
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of polyethylene glycol 3350 in bowel preparation (2 arms), sponsored by Children's Hospital of Philadelphia. Primary endpoint: Efficacy of Colon Preparation. Started Sep 2010; status: terminated.

02

Drugs

polyethylene glycol 3350
03

Conditions

bowel preparation

Beyond the preview

Go deeper on NCT01140295.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01140295.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call